BioSpace News Archive

Avrio Health L.P., a subsidiary of Purdue Pharma L.P., announced the launch of SlowMag® Mg Calm+Sleep, a dietary supplement with Magnesium Citrate and Melatonin.

NEOGEN Corporation’s (NASDAQ: NEOG) Soleris® Direct Yeast and Mold test has received the Performance Tested MethodsSM Certification from the AOAC Research Institute’s Emergency Response Validation Process for the enumeration of yeasts and molds in dried cannabis flower [9-tetrahydrocannabinol (THC) >0.3%].

Novan, Inc. announced the pricing of the Company’s previously announced underwritten public offering of 3,636,364 shares of common stock at a public offering price of $11.00 per share for gross proceeds of approximately $40 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Novan.

Capricor Therapeutics (“Capricor” or “the Company”) (NASDAQ: CAPR), announced today that Capricor CEO, Linda Marbán, Ph.D., will provide an update on recent findings after a preliminary review of the Company’s ongoing open-label extension study of the Phase II HOPE-2 trial with lead asset, CAP-1002, at the Parent Project Muscular Dystrophy (PPMD) 2021 Virtual Annual Conference.

ICON plc announced in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. pursuant to which Indigo Merger Sub, Inc., a wholly owned subsidiary of ICON will merge with and into PRA, with PRA surviving the Merger, the pricing on June 16, 2021 of $500 million aggregate principal amount of Merger Sub’s 2.875% Senior Secured Notes due 2026 in a private offering.

Today, Olympus Corporation of the Americas announced market availability of its 510(k)-cleared Telegraph Evolution® surgical nail system from FH ORTHO, a company that Olympus acquired in November 2020.

The global advanced medical stopcock market is expected to reach US$ 1,167.6 Mn in 2027 from US$ 841.3 Mn in 2018.

The report highlights trends prevailing in the global pulse oximeters market, and drivers and restraints pertaining to the market growth.

A novel synthetic opioid with purported potency greater than fentanyl has emerged in the United States and is linked to a growing number of overdose deaths across at least five states.

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Dr. Stephen S. Tang, President and CEO, will participate in a fireside chat at the Raymond James 2021 Human Health Innovation Conference